Ledger.Open graph →
SEC Form D · filed September 1, 2021

Attivare Therapeutics, Inc

Offering
$6.3M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Other
Location
NATICK, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Joaquim Trias · Natick, MAExec · DirectorZeshan Muhammedi · Natick, MADirectorEdward Doherty · Natick, MAExec · DirectorJessica Mcdonough · Natick, MADirectorRobert Konrad · Delray Beach, FLExec · DirectorRobert Konrad · Delray Beach, FLDirectorCasey Swercheck · Delray Beach, FLExec · DirectorJonathan F. Frangakis · Raleigh, NCDirectorJeffrey W. Koonce · Baton Rouge, LADirectorLuther C. Kissam Iv · Baton Rouge, LADirectorMark W. Spender · Baton Rouge, LAExec · DirectorKathleen M. Courtis · CHICAGO, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗